1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, et al. Cancer Today (powered by GLOBOCAN 2018). IARC CancerBase; 2018.
2. Boufraqech M, Patel D, Xiong Y, Kebebew E. Diagnosis of thyroid cancer: state of art. Expert Opin Med Diagn. 2013;7:331–42.
3. Gou Q, Gao L, Nie X, Pu W, Zhu J, Wang Y, et al. Long noncoding RNA AB074169 inhibits cell proliferation via modulation of KHSRP-mediated CDKN1a expression in papillary thyroid carcinoma. Cancer Res. 2018;78:4163–74.
4. Maksimovic S, Jakovljevic B, Gojkovic Z. Lymph node metastases papillary thyroid carcinoma and their importance in recurrence of disease. Med Arch (Sarajevo, Bosnia Herzeg). 2018;72:108–11.
5. Sun Y, Lv H, Zhang S, Bai Y, Shi B. Gender-specific risk of central compartment lymph node metastasis in papillary thyroid carcinoma. Int J Endocrinol. 2018;2018:6710326.